Brussels, 24 June 2025

The start of the European Commission mandate for 2024-2029 created unprecedented policy action for the biotech and life sciences sectors, with upcoming proposals and initiatives including a European Startup and Scaleup Strategy, Life Sciences Strategy and a Biotech Act.

On April 2, 2025, EuropaBio's National Associations Council hosted the fifth edition of its flagship Presidency event for the fourth consecutive year, together with BioForum, the Polish biotechnology association, in Warsaw, Poland. The session was an in-person, invite-only roundtable discussion.

It gathered participants from the Polish Agency for Medical Research, the Polish Ministry of Development and Technology, national biotech SMEs, mid-sized and multinational companies and national associations from Eastern Europe and the Baltic.

The discussion focused on how Europe can improve public and private funding for biotech startups and scaleups, with a focus on Eastern Europe and the Baltic. This executive report reflects the exchanges of the participants, with further input from the EuropaBio biotechnology national associations and SME members.

Download the full conclusions below